Friday 29 December 2017

Ertugliflozin Approved By US FDA for Treating Type 2 Diabetes

Ertugliflozin has been recently approved by US FDA for monotherapy and as a fixed dose combination to treat type 2 diabetes in adults.


from Medindia Health News http://ift.tt/2EePezq
Posted by at
Labels: ,

1 comment:

Subscribe to: Post Comments (Atom)